This presents the idea that AKT-S cases are much more receptive to IgM engagement compared to p38MAPK-S cases which may help to explain why this subset of patients readily recruits BCR machinery, potentially helping to promote a survival phenotype by CLL cells. Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.